Menu
We are a globally active clinical research institute and platform for academic study groups, dedicated to investigator-initiated and industry-academia collaborative clinical trials in oncology and hematology. Our mission is to close critical gaps in cancer care, advance science-driven research, and accelerate the development of innovative therapies. Through our extensive clinical research infrastructure, strong patient access, and international network, we work together with academic investigators and collaborative groups to transform scientific discoveries into meaningful benefits for patients.
Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients.
Our collaborative models offer academic and biotech partners distinct advantages over traditional CRO approaches
Our team of physicians, who have years of expertise and current knowledge in medical care, are specialized in the fields of hematology, oncology, surgical oncology, palliative medicine, supportive therapy, and human genetics. Our founders are oncologists, and this expertise is a hallmark of IKF.
With well-established networks of almost hundreds of medical institutions, the best experts in their respective fields for every disease type, and the largest academic study groups in Germany and Europe, IKF has a powerful network that sets us apart.
IKF provides well-established access to routine clinical oncology environments through long-term collaborations with university hospitals, other large hospitals, and private oncology practitioners.